jiayi-li23/proxann_data huggingface dataset:
Bill 113-HR-3528 — Health / Drug and Alcohol Abuse
Subject: Health

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2013 - Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of such Act to foster the establishment of state-administered controlled substance monitoring systems in order to ensure that appropriate law enforcement, regulatory, and state professional licensing authorities have access to prescription history information for the purposes of investigating drug diversion and prescribing and dispensing practices of errant prescribers or pharmacists.

Amends the Public Health Service Act to revise and update the controlled substance monitoring program, including to: (1) allow grants to be used to maintain and operate existing state controlled substance monitoring programs, (2) require the Secretary of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, (3) require a state to provide the Secretary with aggregate data and other information to enable the Secretary to evaluate the success of the state's program and to submit a progress report to Congress, and (4) expand the program to include any commonwealth or territory of the United States.

Authorizes the Drug Enforcement Administration (DEA) or a state Medicaid program or state health department receiving nonidentifiable information from a controlled substance monitoring database to make such information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber use of the state's controlled substance monitoring system, and (2) educate prescribers on the benefits of the system both to them and society.

Revises preferences for grants related to drug abuse to authorize the Secretary to give preference to eligible states or tribes that put forth a good faith effort to meet minimum requirements under the controlled substance monitoring program.
Bill 113-HR-3911 — Health / Drug and Alcohol Abuse
Subject: Education

Amends the Safe and Drug-Free Schools and Communities Act to require: (1) states to use grants for safe and drug-free schools to collect and report information on the incidence of bullying and harassment, and (2) local educational agencies (LEAs) and schools to use subgrants to prevent and respond to incidents of bullying and harassment.

Requires such LEAs or schools to: (1) notify parents and students annually of conduct prohibited in their school discipline policies, that now must include bullying and harassment; and (2) establish complaint procedures for students and parents to register complaints regarding such conduct.

Includes bullying and harassment within the Act's definition of violence.
Bill 113-HR-3969 — Health / Drug and Alcohol Abuse
Subject: Health

Preventing Abuse of Cough Treatments Act of 2014 or the PACT Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale or offering for sale of a drug containing dextromethorphan, and not subject to practitioner supervision requirements, to an individual under age 18, except if the sale is made: (1) pursuant to a validly issued prescription; or (2) to an individual who provides proof of being actively enrolled in the military, including a valid military identification card. Imposes civil monetary penalties that escalate upon repeated violation.

Deems to be adulterated any unfinished dextromethorphan that is possessed, received, or distributed in violation of this Act. Prohibits a person from: (1) possessing or receiving unfinished dextromethorphan unless the person is registered with the Secretary of Health and Human Services (HHS) as a producer of a drug or device or otherwise registered, licensed, or approved under federal or state law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients; or (2) distributing unfinished dextromethorphan to any person other than a registered or otherwise authorized person. Excludes from such prohibitions common carriers that possess, receive, or distribute unfinished dextromethorphan for purposes of distributing it between registered, licensed, or approved persons. Imposes additional civil monetary penalties for such possession and distribution violations.
Bill 113-HR-4169 — Health / Drug and Alcohol Abuse
Subject: Health

Stop Overdose Stat Act or the S.O.S. Act - Requires the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) award grants or enter into cooperative agreements to enable eligible entities to reduce deaths occurring from drug overdoses, and (2) give priority to eligible public health agencies or community-based organizations that have expertise in preventing deaths occurring from overdoses in high risk populations.

Conditions receipt of a grant or agreement on an entity agreeing to: (1) use it for purchasing and distributing the drug naloxone, (2) report to the Secretary and the coordinating center (established under this Act) on the results of the activities supported, and (3) make available non-federal contributions of at least 50% of the federal funds provided. Requires a recipient to use such grant or agreement for: (1) educating prescribers and pharmacists about overdose prevention and naloxone prescription; (2) training first responders, other individuals in a position to respond to an overdose, and law enforcement and corrections officials on the effective response to individuals who have overdosed on drugs; (3) implementing and enhancing programs to provide overdose prevention, recognition, treatment, and response; and/or (4) expanding such activities.

Requires the Director to establish and provide for the operation of a coordinating center responsible for: (1) collecting, compiling, disseminating, and evaluating data on such activities; (2) developing best practices for preventing deaths occurring from drug overdoses; and (3) making such best practices specific to the type of community involved.

Requires the Director to award grants or cooperative agreements to improve drug overdose surveillance and reporting capabilities.

Amends the Public Health Service Act to require the Secretary to develop and submit to Congress a plan to reduce the number of deaths occurring from overdoses, to include implementation of a campaign to educate prescribers and the public about overdose prevention and naloxone prescription.

Requires the Director of the National Institute on Drug Abuse to: (1) prioritize and conduct or support research on drug overdose and overdose prevention, and (2) support research on the development of formulations of naloxone and dosage delivery devices specifically intended to be used for the prehospital treatment of unintentional drug overdose.
Bill 113-HR-4288 — Health / Drug and Alcohol Abuse
Subject: Health

Opioid Overdose Reduction Act of 2014 - Exempts from liability for harm caused by the emergency administration of an opioid overdose drug:

 a health care professional who prescribes or provides such a drug to an individual at risk of experiencing an opioid overdose, or to another person in a position to assist such individual, if the individual has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; a person who provides such a drug for emergency administration to an individual authorized to receive it as part of an opioid overdose program; and a person who provides for emergency administration of such a drug to an individual who reasonably appears to have suffered an overdose from heroin or another opioid if such person obtained such drug from a health care professional or as part of an opioid overdose program and was educated by such professional or program in the proper administration of such drug. Makes such exemptions inapplicable if the harm was caused by gross negligence or reckless misconduct.
Bill 113-HR-5339 — Health / Drug and Alcohol Abuse
Subject: Health

Expanding Opportunities for Recovery Act of 2014 - Requires the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states to expand access to clinically appropriate services for opioid abuse or addiction. Requires states to use these grants to provide up to 60 consecutive days of services to individuals who otherwise would not have access to substance abuse services.
Bill 113-HR-5587 — Health / Drug and Alcohol Abuse
Subject: Health

Opioid Abuse Prevention and Treatment Act of 2014 - Requires the Secretary of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive.

Amends the Public Health Service Act to require the Secretary to establish grant programs to: (1) facilitate training to increase the capacity of health care providers to screen and treat patients to prevent drug abuse, and (2) develop continuing education criteria that allow health profession boards or state agencies to certify appropriate education for safe prescribing of schedule II or III drugs. Requires the Administrator of the Health Resources and Services Administration to award grants to evaluate the prospect of state health professions boards expanding the authority of providers to prescribe drugs to treat drug abuse.

Requires the Attorney General to request that practitioners registered to dispense controlled substances screen patients for potential drug abuse before prescribing a schedule II or III drug.

Directs the Food and Drug Administration (FDA) to consider whether naloxone (a prescription drug used to rapidly reverse an overdose of heroin or other opioids, which are drugs with effects similar to opium) should be available without a prescription.

Requires the Secretary to use an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates (drugs derived from opium) and to reduce opportunities for abuse of opiates.

Requires the Government Accountability Office (GAO) to review federal opioid abuse activities and make recommendations to reduce opioid abuse and overdoses.
Bill 113-HR-5762 — Health / Drug and Alcohol Abuse
Subject: Armed forces and national security

Veterans Equal Access Act of 2014 - Directs the Secretary of Veterans Affairs (VA) to authorize VA health care providers to: (1) provide veterans with recommendations and opinions regarding participation in their state's marijuana programs, and (2) complete forms reflecting such recommendations and opinions.
Bill 113-S-237 — Health / Drug and Alcohol Abuse
Subject: Health

Advancing FASD Research, Prevention, and Services Act - Amends the Public Health Service Act to revise and extend the Fetal Alcohol Spectrum Disorders (FASD) programs (as renamed under this Act, previously the Fetal Alcohol Syndrome and Fetal Alcohol Effect programs). Directs the Secretary of Health and Human Services (HHS) to: (1) establish and carry out a research agenda for FASD; (2) facilitate surveillance, public health research, and prevention of FASD; and (3) continue the Interagency Coordinating Committee on Fetal Alcohol Syndrome.

Requires the Secretary to provide financial assistance to: (1) establish or expand state FASD programs; (2) implement best practices to educate children with FASD, educate members of the criminal justice system on FASD, and educate adoption or foster care agency officials about services for children with FASD; (3) provide transitional services for those affected by prenatal alcohol exposure; (4) develop public service announcements to raise awareness of the risks associated with alcohol consumption during pregnancy; (5) increase awareness and identification of FASD in federally qualified health centers; and (6) provide respite care for caretakers, recruit mentors, and provide educational and supportive services to families of individuals with FASD.

Directs the Comptroller General (GAO) to make recommendations regarding the appropriate roles and responsibilities of federal entities with respect to programs and activities related to FASD.

Requires the Secretary of Education to direct the Office of Special Education and Rehabilitative Services to conduct training on FASD surveillance and disseminate best practices in the education and support of children with FASD.

Requires the Attorney General (DOJ) to direct the Office of Juvenile Justice and Delinquency Prevention to: (1) implement FASD screening procedures, (2) conduct training on surveillance and on identification and support of individuals with FASD, and (3) study the inadequacies of the current system.
Bill 113-S-348 — Health / Drug and Alcohol Abuse
Subject: Health

Prescription Drug Abuse Prevention and Treatment Act of 2013 - Amends the Public Health Service Act to direct the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states and nonprofit entities for consumer education about opioid abuse, including methadone abuse.

Amends the Controlled Substances Act to: (1) set forth training requirements for practitioners registered to prescribe or dispense methadone or other opioids, and (2) require each registered opioid treatment clinic to make acceptable arrangements for each patient who is restricted from having a take-home dose of a controlled substance related to treatment to receive a dose of that substance under appropriate supervision when the clinic is closed.

Prohibits any individual or entity (except hospitals that provide direct patient supervision) from prescribing or dispensing a 40-mg diskette of methadone unless such prescription or dispensation is consistent with the current Drug Enforcement Administration (DEA) methadone policy, until the date the Controlled Substances Clinical Standards Commission: (1) publishes dosing guidelines for methadone, and (2) finds that such 40-mg diskettes are safe and clinically appropriate. Requires the Secretary of Health and Human Services (HHS) to establish such Commission to develop and publish guidelines related to methadone use, including safe dosing guidelines for all forms of methadone and benchmark guidelines for the reduction of methadone abuse.

Requires states receiving controlled substances monitoring program grants to: (1) provide information, upon request, to drug enforcement officials relating to an individual who is the subject of an active drug-related investigation; and (2) require opioid-related deaths to be reported to the Administrator.

Directs the Administrator to develop a Model Opioid Treatment Program Mortality Report.

Requires the Administrator to establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry to track opioid-related deaths.

Requires the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to require the development and application of specific prescription drug abuse prevention and treatment quality measures for each relevant health care provider setting.
Bill 113-S-644 — Health / Drug and Alcohol Abuse
Subject: Health

Preventing Abuse of Cough Treatments Act of 2013 or PACT Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale or offering for sale of a drug containing dextromethorphan, and not subject to practitioner supervision requirements, to an individual under age 18, except if the sale is made: (1) pursuant to a validly issued prescription; or (2) to an individual who provides proof of being actively enrolled in the military, including a valid military identification card. Imposes civil monetary penalties that escalate upon repeated violation.

Deems to be adulterated any unfinished dextromethorphan that is possessed, received, or distributed in violation of this Act. Prohibits a person from: (1) possessing or receiving unfinished dextromethorphan unless the person is registered with the Secretary of Health and Human Services (HHS) as a producer of a drug or device or otherwise registered, licensed, or approved under federal or state law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients; or (2) distributing unfinished dextromethorphan to any person other than a registered or otherwise authorized person. Excludes from such prohibitions common carriers that possess, receive, or distribute unfinished dextromethorphan for purposes of distributing it between registered, licensed, or approved persons. Imposes additional civil monetary penalties for such possession and distribution violations.
Bill 113-S-1277 — Health / Drug and Alcohol Abuse
Subject: Health

Combating Prescription Drug Abuse Act - Establishes the Combating Prescription Drug Abuse Commission, whose duties shall be to: (1) review and report to Congress on federal initiatives regarding efforts to prevent and reduce prescription drug abuse, (2) identify gaps and opportunities regarding the safe use of prescription drugs with the potential for diversion and abuse, and (3) make recommendations on specific ways to reduce diversion and abuse of prescription drugs.

Requires the report to describe Commission efforts to prevent or reduce drug diversion and abuse to ensure that patients continue to have access to medications and include specific recommendations for the Drug Enforcement Administration (DEA), the Food and Drug Administration (FDA), and other federal and state agencies concerning prescription drug monitoring and abuse.
Bill 113-S-2092 — Health / Drug and Alcohol Abuse
Subject: Health

Opioid Overdose Reduction Act of 2014 - Exempts from liability for harm caused by the emergency administration of an opioid overdose drug:

 a health care professional who prescribes or provides such a drug to an individual at risk of experiencing an opioid overdose, or to another person in a position to assist such individual, if the individual has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; a person who provides such a drug for emergency administration to an individual authorized to receive it as part of an opioid overdose program; and a person who provides for emergency administration of such a drug to an individual who reasonably appears to have suffered an overdose from heroin or another opioid if such person obtained such drug from a health care professional or as part of an opioid overdose program and was educated by such professional or program in the proper administration of such drug. Makes such exemptions inapplicable if the harm was caused by gross negligence or reckless misconduct.
Bill 113-S-2529 — Health / Drug and Alcohol Abuse
Subject: Health

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014 - Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of such Act to foster the establishment of state-administered controlled substance monitoring systems in order to ensure that appropriate law enforcement, regulatory, and state professional licensing authorities have access to prescription history information for the purposes of investigating drug diversion and prescribing and dispensing practices of errant prescribers or pharmacists.

 Amends the Public Health Service Act to revise and update the controlled substance monitoring program, including to:

 allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require submission by a state of a plan to apply the latest advances in health information technology to incorporate prescription drug monitoring program data directly into the workflow of prescribers and dispensers, require timelines and descriptions for implementation of interoperability for purposes of information sharing with a bordering state that already operates a monitoring program, require health information interoperability standards to be consistent with at least one health information technology system, require the Secretary of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide the Secretary with aggregate data and other information to enable the Secretary to evaluate the success of the state's program and to submit a progress report to Congress, and expand the program to include any commonwealth or territory of the United States. Authorizes the Drug Enforcement Administration (DEA) or a state Medicaid program or health department receiving nonidentifiable information from a controlled substance monitoring database to make such information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

 Removes the preferences for grants related to drug abuse for states with approved applications to implement controlled substances monitoring programs.

Revises requirements for studies on progress to include assessment of the effects upon linkages to substance abuse disorder services and interoperability with health information technology systems.
Bill 113-S-2755 — Health / Drug and Alcohol Abuse
Subject: Health

Overdose Prevention Act - Amends the Public Health Service Act to require the Director of the Centers for Disease Control and Prevention (CDC) to enter into cooperative agreements to reduce deaths from drug overdoses by: (1) purchasing and distributing naloxone (a medication that rapidly reverses overdose from heroin or other opioids, which are drugs with effects similar to opium) or a similar drug; and (2) educating or training the public, first responders, or health professionals on drug overdose prevention or response. Requires the CDC to improve drug overdose surveillance by entering into cooperative agreements to: (1) provide training to improve identification of drug overdose as the cause of death, and (2) establish a national program for reporting drug overdoses.

Directs the Secretary of Health and Human Services (HHS) to establish a coordinating center and develop a plan to reduce drug overdose deaths by educating the public about overdose prevention and recommending improvements to overdose prevention programs.

Requires the Director of the National Institute on Drug Abuse (NIDA) to prioritize, conduct, and support research on circumstances that contribute to drug overdose, drugs associated with fatal overdose, and overdose prevention methods. Directs NIDA to support research on drug overdose treatments that can be administered by lay persons or first responders.